178 related articles for article (PubMed ID: 11089886)
1. Simultaneous up-regulation of urokinase-type plasminogen activator (uPA) and uPA receptor by hepatocyte growth factor/scatter factor in human glioma cells.
Moriyama T; Kataoka H; Hamasuna R; Yoshida E; Sameshima T; Iseda T; Yokogami K; Nakano S; Koono M; Wakisaka S
Clin Exp Metastasis; 1999; 17(10):873-9. PubMed ID: 11089886
[TBL] [Abstract][Full Text] [Related]
2. The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor-met-urokinase plasminogen activator-plasmin proteolytic network.
Webb CP; Hose CD; Koochekpour S; Jeffers M; Oskarsson M; Sausville E; Monks A; Vande Woude GF
Cancer Res; 2000 Jan; 60(2):342-9. PubMed ID: 10667586
[TBL] [Abstract][Full Text] [Related]
3. Activation of the urokinase plasminogen activator/urokinase plasminogen activator receptor system and redistribution of E-cadherin are associated with hepatocyte growth factor-induced motility of pancreas tumor cells overexpressing Met.
Paciucci R; Vilá MR; Adell T; Díaz VM; Torà M; Nakamura T; Real FX
Am J Pathol; 1998 Jul; 153(1):201-12. PubMed ID: 9665481
[TBL] [Abstract][Full Text] [Related]
4. Effects of hepatocyte growth factor on urokinase-type plasminogen activator (uPA) and uPA receptor in DU145 prostate cancer cells.
Nishimura K; Matsumiya K; Miura H; Tsujimura A; Nonomura N; Matsumoto K; Nakamura T; Okuyama A
Int J Androl; 2003 Jun; 26(3):175-9. PubMed ID: 12755996
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of urokinase-type plasminogen activator and its receptor correlates with enhanced invasion activity of human glioma cells mediated by transforming growth factor-alpha or basic fibroblast growth factor.
Mori T; Abe T; Wakabayashi Y; Hikawa T; Matsuo K; Yamada Y; Kuwano M; Hori S
J Neurooncol; 2000; 46(2):115-23. PubMed ID: 10894364
[TBL] [Abstract][Full Text] [Related]
6. Insulinlike growth factor-I-mediated migration and invasion of human colon carcinoma cells requires activation of c-Met and urokinase plasminogen activator receptor.
Bauer TW; Fan F; Liu W; Johnson M; Parikh NU; Parry GC; Callahan J; Mazar AP; Gallick GE; Ellis LM
Ann Surg; 2005 May; 241(5):748-56; discussion 756-8. PubMed ID: 15849510
[TBL] [Abstract][Full Text] [Related]
7. Activation mechanisms of the urokinase-type plasminogen activator promoter by hepatocyte growth factor/scatter factor.
Ried S; Jäger C; Jeffers M; Vande Woude GF; Graeff H; Schmitt M; Lengyel E
J Biol Chem; 1999 Jun; 274(23):16377-86. PubMed ID: 10347197
[TBL] [Abstract][Full Text] [Related]
8. Role of hepatocyte growth factor/c-Met signaling in regulating urokinase plasminogen activator on invasiveness in human hepatocellular carcinoma: a potential therapeutic target.
Lee KH; Choi EY; Hyun MS; Jang BI; Kim TN; Lee HJ; Eun JY; Kim HG; Yoon SS; Lee DS; Kim JH; Kim JR
Clin Exp Metastasis; 2008; 25(1):89-96. PubMed ID: 17992475
[TBL] [Abstract][Full Text] [Related]
9. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
[TBL] [Abstract][Full Text] [Related]
10. Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signalling in human cells concomitant with induction of the urokinase proteolysis network.
Jeffers M; Rong S; Vande Woude GF
Mol Cell Biol; 1996 Mar; 16(3):1115-25. PubMed ID: 8622656
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte growth factor/scatter factor promotes retinal angiogenesis through increased urokinase expression.
Colombo ES; Menicucci G; McGuire PG; Das A
Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1793-800. PubMed ID: 17389513
[TBL] [Abstract][Full Text] [Related]
12. Urokinase type plasminogen activator and its receptor regulate the invasive potential of gastric cancer cell lines.
Okusa Y; Ichikura T; Mochizuki H; Shinomiya N
Int J Oncol; 2000 Nov; 17(5):1001-5. PubMed ID: 11029504
[TBL] [Abstract][Full Text] [Related]
13. Role of the plasminogen activator and matrix metalloproteinase systems in epidermal growth factor- and scatter factor-stimulated invasion of carcinoma cells.
Rosenthal EL; Johnson TM; Allen ED; Apel IJ; Punturieri A; Weiss SJ
Cancer Res; 1998 Nov; 58(22):5221-30. PubMed ID: 9823336
[TBL] [Abstract][Full Text] [Related]
14. Hepatocyte growth factor/c-met signaling in regulating urokinase plasminogen activator in human stomach cancer: A potential therapeutic target for human stomach cancer.
Lee KH; Choi EY; Hyun MS; Jang BI; Kim TN; Kim SW; Song SK; Kim JH; Kim JR
Korean J Intern Med; 2006 Mar; 21(1):20-7. PubMed ID: 16646560
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of vascular endothelial growth factor induced by hepatocyte growth factor/scatter factor stimulation in human glioma cells.
Moriyama T; Kataoka H; Hamasuna R; Yokogami K; Uehara H; Kawano H; Goya T; Tsubouchi H; Koono M; Wakisaka S
Biochem Biophys Res Commun; 1998 Aug; 249(1):73-7. PubMed ID: 9705834
[TBL] [Abstract][Full Text] [Related]
16. Geldanamycins exquisitely inhibit HGF/SF-mediated tumor cell invasion.
Xie Q; Gao CF; Shinomiya N; Sausville E; Hay R; Gustafson M; Shen Y; Wenkert D; Vande Woude GF
Oncogene; 2005 May; 24(23):3697-707. PubMed ID: 15782129
[TBL] [Abstract][Full Text] [Related]
17. Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor.
Naldini L; Tamagnone L; Vigna E; Sachs M; Hartmann G; Birchmeier W; Daikuhara Y; Tsubouchi H; Blasi F; Comoglio PM
EMBO J; 1992 Dec; 11(13):4825-33. PubMed ID: 1334458
[TBL] [Abstract][Full Text] [Related]
18. Elevated urokinase-specific surface receptor expression is maintained through its interaction with urokinase plasminogen activator.
Mahanivong C; Yu J; Huang S
Mol Carcinog; 2007 Mar; 46(3):165-75. PubMed ID: 17186542
[TBL] [Abstract][Full Text] [Related]
19. Urokinase-type plasminogen activator increases hepatocyte growth factor activity required for skeletal muscle regeneration.
Sisson TH; Nguyen MH; Yu B; Novak ML; Simon RH; Koh TJ
Blood; 2009 Dec; 114(24):5052-61. PubMed ID: 19812386
[TBL] [Abstract][Full Text] [Related]
20. Exploitation of astrocytes by glioma cells to facilitate invasiveness: a mechanism involving matrix metalloproteinase-2 and the urokinase-type plasminogen activator-plasmin cascade.
Le DM; Besson A; Fogg DK; Choi KS; Waisman DM; Goodyer CG; Rewcastle B; Yong VW
J Neurosci; 2003 May; 23(10):4034-43. PubMed ID: 12764090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
